Adenosine- and 2-chloro-adenosine-induced cytopathic effects on myoblastic cells and myotubes: involvement of different intracellular mechanisms

[1]  G. Dickson,et al.  Cationic Lipids and Polymers Are Able to Enhance Adenoviral Infection of Cultured Mouse Myotubes , 1999, Journal of neurochemistry.

[2]  Xiaodong Wang,et al.  Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Rounds,et al.  Mechanism of extracellular ATP- and adenosine-induced apoptosis of cultured pulmonary artery endothelial cells. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[4]  P. Matarrese,et al.  Antiproliferative activity of interferon α and retinoic acid in SiHa carcinoma cells: The role of cell adhesion , 1998, International journal of cancer.

[5]  C. Franceschi,et al.  Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells , 1998, Neurochemistry International.

[6]  P. Matarrese,et al.  The HIV-1 vpr Protein Acts as a Negative Regulator of Apoptosis in a Human Lymphoblastoid T Cell Line: Possible Implications for the Pathogenesis of AIDS , 1998, The Journal of experimental medicine.

[7]  C. Franceschi,et al.  Modulation of Apoptosis by Adenosine in the Central Nervous System: a Possible Role for the A3 Receptor , 1997, Annals of the New York Academy of Sciences.

[8]  C. Franceschi,et al.  Actin cytoskeleton as a target for 2-chloro adenosine: evidence for induction of apoptosis in C2C12 myoblastic cells. , 1997, Biochemical and biophysical research communications.

[9]  D. Agrawal,et al.  Morphological and biochemical characterization and analysis of apoptosis. , 1997, Journal of pharmacological and toxicological methods.

[10]  T. Badea,et al.  Sublytic Terminal Complement Attack on Myotubes Decreases the Expression of mRNAs Encoding Muscle‐Specific Proteins , 1997, Journal of neurochemistry.

[11]  W. Malorni,et al.  Different pathways of apoptosis revealed by 2‐chloro‐adenosine and deoxy‐D‐ribose in mammalian astroglial cells , 1997, Journal of neuroscience research.

[12]  E. Engvall,et al.  Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival , 1996, The Journal of cell biology.

[13]  K. Walsh,et al.  Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation , 1996, Science.

[14]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[15]  H. Gordon,et al.  Altered Glycosaminoglycan Chain Structure in a Variant of the C2 Mouse Muscle Cell Line , 1996, Journal of neurochemistry.

[16]  R K Gordon,et al.  S‐Adenosylmetliionine and methylation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Burnstock,et al.  Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells , 1996, Trends in Neurosciences.

[18]  A. Cossarizza,et al.  Control of apoptosis by the cellular ATP level , 1996, FEBS letters.

[19]  M. Castro‐Gago,et al.  Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[20]  P. Schofield,et al.  Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II. , 1995, Cell death and differentiation.

[21]  D. Przywara,et al.  Adenosine‐induced apoptosis in chick embryonic sympathetic neurons: a new physiological role for adenosine. , 1995, The Journal of physiology.

[22]  Tallman,et al.  Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders [published erratum appears in Blood 1996 Mar 1;87(5):2093] , 1995 .

[23]  M. Reedy,et al.  Maintenance of the differentiated state in skeletal muscle: activation of v-Src disrupts sarcomeres in quail myotubes , 1995, The Journal of cell biology.

[24]  Z. Szondy.  Adenosine stimulates DNA fragmentation in human thymocytes by Ca(2+)-mediated mechanisms. , 1994, The Biochemical journal.

[25]  K. Schulze-Osthoff,et al.  Adenosine and homocysteine together enhance TNF-mediated cytotoxicity but do not alter activation of nuclear factor-kappa B in L929 cells. , 1994, Journal of immunology.

[26]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[27]  G. Donelli,et al.  N‐Acetylcysteine inhibits apoptosis and decreases viral particles in HIV‐chronically infected U937 cells , 1993, FEBS letters.

[28]  H. Goebel,et al.  Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. , 1990, Brain : a journal of neurology.

[29]  M. Castro‐Gago,et al.  Effects of chronic allopurinol therapy on purine metabolism in Duchenne muscular dystrophy. , 1987, Biochemical and biophysical research communications.

[30]  D. Carson,et al.  Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. , 1985, The Journal of clinical investigation.

[31]  P. Ueland.  Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. , 1982, Pharmacological reviews.

[32]  B. Nadal-Ginard,et al.  Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis , 1978, Cell.

[33]  J. Dow,et al.  The dictionary of cell biology. , 1989 .

[34]  D. Martin,et al.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. , 1978, Proceedings of the National Academy of Sciences of the United States of America.